SRINIVAS AKKARAJU Insider Trading $SYRS Syros Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SRINIVAS AKKARAJU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SRINIVAS AKKARAJU. SRINIVAS AKKARAJU is Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in aTYR PHARMA INC ($LIFE) and Director in ADURO BIOTECH, INC. ($ADRO) and Director in ZS Pharma, Inc. ($ZSPH) and Director in Principia Biopharma Inc. ($PRNB) and Director in Versartis, Inc. ($VSAR) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Jiya Acquisition Corp. ($JYAC).
SRINIVAS AKKARAJU in Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 1,899,616 shares
Current Value: $20,743,807
Latest Transaction: Dec 11 2020
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SRINIVAS AKKARAJU in Syros Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, LIFE, ADRO, ICPT, JYAC, PRNB, SGEN, SYRS, ZSPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 11.00 | 156,250 | 1,718,750 | 156,250 | |
| Dec 11 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 625,000 | 0 | 1,899,616 | 1.3 M to 1.9 M (+49.03 %) |
| Aug 19 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 13.10 | 158,583 | 2,076,724 | 1,274,616 | 1.4 M to 1.3 M (-11.06 %) |
| Aug 19 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 13.00 | 744 | 9,672 | 1,433,199 | 1.4 M to 1.4 M (-0.05 %) |
| Jul 06 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.01 | 4,627 | 50,966 | 1,433,943 | 1.4 M to 1.4 M (-0.32 %) |
| Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.15 | 54,972 | 612,850 | 1,438,570 | 1.5 M to 1.4 M (-3.68 %) |
| Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.07 | 48,775 | 539,788 | 1,493,542 | 1.5 M to 1.5 M (-3.16 %) |
| Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.11 | 50,953 | 565,930 | 1,542,317 | 1.6 M to 1.5 M (-3.20 %) |
| Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.15 | 54,972 | 612,850 | 1,438,570 | 1.5 M to 1.4 M (-3.68 %) |
| Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.07 | 48,775 | 539,788 | 1,493,542 | 1.5 M to 1.5 M (-3.16 %) |
| Jun 25 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Sell | S | 11.11 | 50,953 | 565,930 | 1,542,317 | 1.6 M to 1.5 M (-3.20 %) |
| Jun 11 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
| Jun 12 2019 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
| Apr 11 2019 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | P | 8.63 | 133,333 | 1,149,997 | 133,333 | |
| Apr 11 2019 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 7.50 | 533,332 | 3,999,990 | 1,593,270 | 1.1 M to 1.6 M (+50.32 %) |
| Jun 15 2018 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
| Feb 02 2018 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 9.55 | 209,424 | 1,999,999 | 1,059,938 | 850.5 K to 1.1 M (+24.62 %) |
| Dec 14 2017 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 8.99 | 26,600 | 239,134 | 830,494 | 803.9 K to 830.5 K (+3.31 %) |
| Dec 14 2017 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 8.97 | 68,400 | 613,548 | 803,894 | 735.5 K to 803.9 K (+9.30 %) |
| Dec 14 2017 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 9.40 | 14,774 | 138,876 | 735,494 | 720.7 K to 735.5 K (+2.05 %) |
| Jun 12 2017 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 14.26 | 22,000 | 313,720 | 22,000 |
Page: 1